Home > Insider Trading > Filing (0001209191-11-029544)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1087432	Intermune Inc	ITMN	Pharmaceutical Preparations (2834)	943296648

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1206199	G Daniel Welch	3280 Bayshore Boulevard Brisbane CA 94005	Chairman, Ceo And President	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2011-05-16	1,608	$38.00	283,535	No	4	F	Direct
Common Stock	Disposition	2011-05-16	3,505	$38.22	280,030	No	4	S	Direct
Common Stock	Disposition	2011-05-18	20,750	$37.22	259,280	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The shares sold in this transaction were acquired pursuant to a restricted stock award granted in May of 2007. The number of shares sold were only that which was necessary to cover the taxes owed upon the vesting of such restricted stock award.
These transactions were made pursuant to a 10b5-1 trading plan entered into in the fourth quarter of 2010 and in effect at the time of the transactions. The transactions were pre-determined in the trading plan to occur at specific dates and share prices of InterMune.
Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $38.18 to $38.24 per share. Full information on the numbers of shares sold at each sale price is available upon request.
Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $37.01 to $37.36 per share. Full information on the numbers of shares sold at each sale price is available upon request.